Congress finally probes link between pharma and researchers

Asbestos in particular, and science in general, have long been characterized by corrupt associations between researchers dependent on funding and pharmaceutical companies dependent on positive research outcomes in order to win FDA approval. The funding effect–a statistically bulletproof, demonstrable relationship between the funding source and a positive research outcome–is so well known that all reputable medical journals require funding source disclosure by researchers prior to publication.

Excellent books like “Doubt is their Product” by David Michaels and “Bending Science” by McGarity and Wagner explore this in detail.

Senators Grassley and Kohl have decided to probe more deeply for information about the financial links between researchers and companies that manufacture cardiovascular medical products. Story reported by the NYT.

Advertisements

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: